IE44603B1 - 2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives - Google Patents

2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives

Info

Publication number
IE44603B1
IE44603B1 IE297/77A IE29777A IE44603B1 IE 44603 B1 IE44603 B1 IE 44603B1 IE 297/77 A IE297/77 A IE 297/77A IE 29777 A IE29777 A IE 29777A IE 44603 B1 IE44603 B1 IE 44603B1
Authority
IE
Ireland
Prior art keywords
mixture
group
compound
oxo
dihydro
Prior art date
Application number
IE297/77A
Other languages
English (en)
Other versions
IE44603L (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/748,851 external-priority patent/US4082751A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IE44603L publication Critical patent/IE44603L/xx
Publication of IE44603B1 publication Critical patent/IE44603B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IE297/77A 1976-02-13 1977-02-11 2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives IE44603B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65778776A 1976-02-13 1976-02-13
US05/748,851 US4082751A (en) 1976-02-13 1976-12-08 Therapeutic agents

Publications (2)

Publication Number Publication Date
IE44603L IE44603L (en) 1977-08-13
IE44603B1 true IE44603B1 (en) 1982-01-27

Family

ID=27097492

Family Applications (1)

Application Number Title Priority Date Filing Date
IE297/77A IE44603B1 (en) 1976-02-13 1977-02-11 2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives

Country Status (14)

Country Link
JP (1) JPS52118481A (da)
AU (1) AU508970B2 (da)
CA (1) CA1083152A (da)
CH (1) CH635339A5 (da)
DE (1) DE2705609A1 (da)
DK (1) DK149044C (da)
FI (1) FI62533C (da)
FR (1) FR2340943A1 (da)
GB (1) GB1541351A (da)
IE (1) IE44603B1 (da)
LU (1) LU76722A1 (da)
NL (1) NL173055C (da)
SE (1) SE433494B (da)
YU (1) YU41567B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883653A (en) * 1972-10-24 1975-05-13 Pfizer Method of preventing asthmatic symptoms

Also Published As

Publication number Publication date
JPS52118481A (en) 1977-10-04
FI62533C (fi) 1983-01-10
FR2340943A1 (fr) 1977-09-09
NL173055C (nl) 1983-12-01
DE2705609A1 (de) 1977-08-25
FI62533B (fi) 1982-09-30
AU508970B2 (en) 1980-04-17
FI770427A (da) 1977-08-14
YU35477A (en) 1982-10-31
AU2189577A (en) 1978-08-10
YU41567B (en) 1987-10-31
DE2705609C2 (da) 1988-12-15
LU76722A1 (da) 1977-08-18
DK57377A (da) 1977-08-14
FR2340943B1 (da) 1981-01-09
NL7701483A (nl) 1977-08-16
DK149044B (da) 1985-12-30
CA1083152A (en) 1980-08-05
IE44603L (en) 1977-08-13
NL173055B (nl) 1983-07-01
SE7701552L (sv) 1977-09-23
JPS6139947B2 (da) 1986-09-06
SE433494B (sv) 1984-05-28
GB1541351A (en) 1979-02-28
DK149044C (da) 1986-06-02
CH635339A5 (en) 1983-03-31

Similar Documents

Publication Publication Date Title
CA1098520A (en) Optionally substituted 3-(1h-tetrazol-5-yl)-4h- pyrido¬1,2-a| pyrimidin-4-ones
US3883653A (en) Method of preventing asthmatic symptoms
CA1315287C (en) Substituted bis-(4-aminophenyl)-sulfones, their preparation and their use as pharmaceutical compositions
JPH09301958A (ja) 新規ピリミジン化合物及び抗ロタウイルス剤
FI61688B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara oxminsyraderivat
US4082751A (en) Therapeutic agents
US4031093A (en) 1,6-Dihydro-6-oxo-2-(ortho-substituted phenyl)pyrimidine-5-carboxylic acid derivatives
IE44603B1 (en) 2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives
EP0244201B1 (en) 3-hydroxypyridines
JPS6160072B2 (da)
CA1117112A (en) Pyrido¬1,2-a|pyrimidine-3-n-(1h-tetrazol-5-yl| carboxamide derivatives
US3927214A (en) Method of preventing asthmatic symptoms
US3957784A (en) Bis(4-[4'-hydroxy-5'-carboxy-2'-pyrimidinyl]phenoxy)alkanes
US3968213A (en) Method of preventing asthmatic symptoms
US4096153A (en) Arylene-bis-tetrazole-5-carboxamides
EP0064385B1 (en) 2,6-diaryl-pyridinecarboxylic acids and their therapeutic utility
SU1342410A3 (ru) Способ получени диазинсодержащих производных оксаминовой кислоты или их солей с первичными или вторичными аминами,или щелочными металлами,или кислотно-аддитивных солей с минеральными кислотами
US3927215A (en) Method of preventing asthmatic symptoms
US3974161A (en) Fused pyrimidin-4(3H)-ones as antiallergy agents
EP0050977B1 (en) Carboxamide compounds as srs-a antagonists and a process for producing same
US3917835A (en) A method of preventing asthmatic symptoms
US4254126A (en) 4-Carbethoxy-carbonilamino-pyrimidines and a process for their preparation
US4330555A (en) Indanyloxamic derivatives, their preparation and pharmaceutical compositions containing them
KR800001139B1 (ko) N-(5-테트라졸릴)-4-옥소-4H-피리미도[2,1-b]벤조티아졸류의 제조방법
JPS6238356B2 (da)